Financial Services (Speciality Finance)
Amphion invests in and develops high growth companies in the medical, life science and technology sectors, by using a focused, hands-on approach, based on decades of experience in disciplined investment and operations both in the US and the UK. Amphion has a significant shareholding in seven Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the partner companies. The partner companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.